Chondroitin / glucosamine / methylsulfonylmethane Alternatives Compared
| Chondroitin / glucosamine / methylsulfonylmethane | Meloxicam | Celebrex (celecoxib) |
|
|---|
| Chondroitin / glucosamine / methylsulfonylmethane | Meloxicam | Celebrex (celecoxib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Over-the-counter
Prescribed for Osteoarthritis, Dietary Supplementation. Chondroitin / glucosamine / methylsulfonylmethane may also be used for purposes not listed in this medication guide. |
Prescription only
Meloxicam is effective for the short-term relief of pain and inflammation associated with arthritis; however, like other NSAIDs, it has the potential to adversely affect the stomach or heart and... View more |
Prescription only
Celebrex is a COX-2-specific NSAID that has a lower propensity for gastrointestinal side effects than many other NSAIDs; however, it still may increase the risk of serious cardiovascular thrombotic... View more |
Related suggestions Osteoarthritis
|
|||||||||||||||
| More about Chondroitin / glucosamine / methylsulfonylmethane | More about Meloxicam | More about Celebrex (celecoxib) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Chondroitin / glucosamine / methylsulfonylmethane has an average rating of 8.3 out of 10 from a total of 17 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 13% reported a negative effect. |
Meloxicam has an average rating of 6.3 out of 10 from a total of 595 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 34% reported a negative effect. |
Celebrex has an average rating of 7.1 out of 10 from a total of 224 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
Chondroitin / glucosamine / methylsulfonylmethane side effects |
||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Meloxicam prices |
View all Celebrex prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Glucosamine & Chondroitin with MSM, Osteo Bi-Flex Advanced, Osteo Bi-Flex Plus MSM, Wellesse Joint Movement Glucosamine | Mobic | Other celecoxib brands include: Elyxyb | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
N/A |
20 hours |
11 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category N
Not classified
|
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 3 drugs are known to interact with Chondroitin / glucosamine / methylsulfonylmethane:
|
A total of 394 drugs are known to interact with Meloxicam:
|
A total of 427 drugs are known to interact with Celebrex:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
April 13, 2000 |
December 31, 1998 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.